Michael J. Fox - 05 Jun 2024 Form 3 Insider Report for Cue Biopharma, Inc. (CUE)

Role
Director
Signature
/s/ Michael J. Fox by Colin Sandercock, attorney-in-fact
Issuer symbol
CUE
Transactions as of
05 Jun 2024
Net transactions value
$0
Form type
3
Filing time
07 Jun 2024, 16:00:05 UTC
Previous filing
28 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CUE Common Stock 1,000,000 05 Jun 2024 By Park City Capital Offshore Master, Ltd. F1
holding CUE Common Stock 100,000 05 Jun 2024 By MF Capital Partners, LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is the managing member of the investment manager of the fund that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2 The reporting person is the managing member of the fund that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Remarks:

Exhibit 24.1 - Power of Attorney